7-77196509-C-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_006682.3(FGL2):c.1090G>T(p.Asp364Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006682.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGL2 | ENST00000248598.6 | c.1090G>T | p.Asp364Tyr | missense_variant | Exon 2 of 2 | 1 | NM_006682.3 | ENSP00000248598.5 | ||
CCDC146 | ENST00000285871.5 | c.156+28685C>A | intron_variant | Intron 2 of 18 | 1 | NM_020879.3 | ENSP00000285871.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1090G>T (p.D364Y) alteration is located in exon 2 (coding exon 2) of the FGL2 gene. This alteration results from a G to T substitution at nucleotide position 1090, causing the aspartic acid (D) at amino acid position 364 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.